3D-Printed mesh aims to improve breast reconstruction outcomes

NCT ID NCT07365267

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new 3D-printed biodegradable mesh used with a silicone implant for immediate breast reconstruction after mastectomy in women with breast cancer. The goal is to see if the mesh improves cosmetic results, patient satisfaction, and safety. The trial will enroll 25 women at one hospital and follow them for outcomes like satisfaction and recurrence.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
3D-printed biodegradable biological mesh
What this could lead to
If successful, this mesh could improve cosmetic results and quality of life for women undergoing immediate breast reconstruction after mastectomy.
What could go wrong
This is a small, early-stage trial with only 25 participants at one center, so results may not apply broadly. Risks include infection, implant issues, or mesh-related complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for 3D-PRINTED BIODEGRADABLE BIOLOGICAL MESH are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • the First Affiliated Hospital of the Air Force Medical University

    RECRUITING

    Xi'an, Shaanxi, 710032, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.